Responses of German cockroaches, Blattella germanica (L.) (Dictyoptera: Blattellidae), to microencapsulated (ME) formulations of six insecticides (bifenthrin, chlorpyrifos, cyfluthrin, deltamethrin, lambda-cyhalothrin, and permethrin) were compared with emulsifiable concentrates (EC) (chlorpyrifos, cyfluthrin, deltamethrin, and permethrin) or ready-to-use (RTU) formulations (bifenthin and lambda-cyhalothrin). Two rates were tested per comparison. Baseline toxicity (LT50 value) was determined by continuous exposure to residual deposits. Repellency, toxicity (LT50), and performance index (PI) values were determined using Ebeling choice boxes. Baseline toxicity of the permethrin formulations was similar, but all other active ingredients had significant toxicity differences at one or both formulation x dose comparisons. Baseline toxicity and repellency were negatively correlated. Choice box LT50 and the time to reach 50% of the maximum PI were positively correlated. The maximum PI was positively correlated (P < 0.06) with baseline LT50 and negatively correlated (P < 0.07) with repellency. Chlorpyrifos had the lowest repellency except for the EC at 0.25%. Bifenthrin ME and lambda-cyhalothrin ME had greater PI values than comparative RTU formulations. Cyfluthrin EC at 0.03% and deltamethrin ME at 0.01% had significantly lower PI values than comparison treatments. Permethrin PI value for the EC at 0.03% exceeded that for the ME, but at 0.05% the ME had a significantly greater PI. These data demonstrate the difficulty in making generalizations about the relative performance of ME compared with EC or RTU formulations. Variable results observed within, and between, formulations may be influenced by application rate, formulation type, other formulation components, and the toxicity-repellency of the active ingredient.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1603/ec09415 | DOI Listing |
Adv Ther
September 2024
NorthStar Consulting, LLC, Davis, CA, USA.
Introduction: There is a medical need for a safe, effective nonopioid postoperative analgesic for older subjects, including those with mild to moderate renal impairment.
Methods: Participants (≥ 65 years) were stratified by no, mild, or moderate renal impairment defined as creatinine clearance 60-89 mL/min for mild and 30-59 mL/min for moderate. Subjects were randomized to receive a loading dose of 6.
Biotechnol Biofuels Bioprod
July 2024
Water Systems and Biotechnology Institute, Faculty of Natural Sciences and Technology, Riga Technical University, Kipsalas Iela 6a, Riga, Latvia.
Background: Achieving climate neutrality is a goal that calls for action in all sectors. The requirements for improving waste management and reducing carbon emissions from the energy sector present an opportunity for wastewater treatment plants (WWTPs) to introduce sustainable waste treatment practices. A common biotechnological approach for waste valorization is the production of sugars from lignocellulosic waste biomass via biological hydrolysis.
View Article and Find Full Text PDFJ Cosmet Dermatol
September 2024
Galderma, Uppsala, Sweden.
Background: Botulinum neurotoxin type A (BoNT-A) is well-established for treatment of glabellar lines (GLs), and mostly formulated as powders requiring reconstitution for injection. The approved liquid formulation, ready-to-use (RTU) abobotulinumtoxinA was developed to ease injection procedures and prevent reconstitution errors. This multicenter, open-label, Phase IV study evaluated GL treatment experience using RTU abobotulinumtoxinA versus powder BoNT-A (onabotulinumtoxinA).
View Article and Find Full Text PDFClin Pharmacol Drug Dev
June 2024
Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA.
Gerodontology
December 2023
Department of Oral Sciences, Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, Dunedin, New Zealand.
Objectives: The objective of this scoping review was to map evidence of electrolysed oxidising water (EOW) as a biocide for dental applications of relevance to older people and identify research gaps.
Background: EOW is an emerging, "green," and cost-effective biocide. There are no reviews on the landscape of EOW research as either an antiseptic or disinfectant in dental healthcare or its suitability for the oral healthcare of older people.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!